These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6287828)

  • 1. Measles immunity and immunization in developing countries of Africa: a review.
    Abdurrahman MB; Taqi AM
    Afr J Med Med Sci; 1981; 10(1-2):57-62. PubMed ID: 6287828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-dose measles vaccination schedules.
    Rosenthal SR; Clements CJ
    Bull World Health Organ; 1993; 71(3-4):421-8. PubMed ID: 8324862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
    Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
    Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles vaccination timing: finding the right age.
    Sieving RE
    Int Nurs Rev; 1988; 35(1):17-21. PubMed ID: 3343087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Measles vaccination and age].
    Aaby P; Andersen M; Sodemann M; Jakobsen M; Gomes J; Fernandes M
    Ugeskr Laeger; 1994 Oct; 156(40):5857-61. PubMed ID: 7985279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles control in developing and developed countries: the case for a two-dose policy.
    Tulchinsky TH; Ginsberg GM; Abed Y; Angeles MT; Akukwe C; Bonn J
    Bull World Health Organ; 1993; 71(1):93-103. PubMed ID: 8440043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Optimal age for vaccination against measles].
    José MV; Kumate J
    Salud Publica Mex; 1989; 31(5):645-57. PubMed ID: 2692194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles in infants: a review of studies on incidence, vaccine efficacy and mortality in east Africa.
    Burström B; Aaby P; Mutie DM
    East Afr Med J; 1995 Mar; 72(3):155-61. PubMed ID: 7796766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles immunization research: a review.
    Aaby P; Clements CJ
    Bull World Health Organ; 1989; 67(4):443-8. PubMed ID: 2680141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting and comparing long-term measles antibody profiles of different immunization policies.
    Lee MS; Nokes DJ
    Bull World Health Organ; 2001; 79(7):615-24. PubMed ID: 11477964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A non-specific, beneficial effect of measles vaccination. Analysis of mortality studies from developing countries].
    Aaby MP; Samb B; Simondon F; Seck AM; Knudsen KM; Whittle H
    Ugeskr Laeger; 1996 Oct; 158(42):5944-8. PubMed ID: 8928283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles antibody levels from birth to 9 months of age in Nigerian infants.
    Abdurrahman MB; Greenwood BM; Olafimihan O; Whitle HC
    Afr J Med Med Sci; 1982 Sep; 11(3):113-5. PubMed ID: 6307026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.
    Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL
    Vaccine; 2006 Jan; 24(5):683-90. PubMed ID: 16154241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up of infants given measles vaccine at 6 months of age: antibody and CMI responses to MMRII at 15 months of age and antibody levels at 27 months of age.
    Carson MM; Spady DW; Beeler JA; Krezolek MP; Audet S; Pabst HF
    Vaccine; 2005 May; 23(25):3247-55. PubMed ID: 15837229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles in a west African nomadic community.
    Loutan L; Paillard S
    Bull World Health Organ; 1992; 70(6):741-4. PubMed ID: 1486670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal age for vaccinating Nigerian children against measles. II. Seroconversion to measles vaccine in different age groups.
    Ogunmekan DA; Harry TO
    Trop Geogr Med; 1981 Dec; 33(4):379-82. PubMed ID: 7342385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Worldwide measles prevention.
    Orenstein WA; Markowitz LE; Atkinson WL; Hinman AR
    Isr J Med Sci; 1994; 30(5-6):469-81. PubMed ID: 8034506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass measles control in West and Central Africa.
    Foster SO; Pifer JM
    Afr J Med Sci; 1971 Apr; 2(2):151-8. PubMed ID: 5111614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The WHO Global Programme for Vaccines and Immunization Vaccine Trial Registry.
    Robertson SE; Mayans MV; Horsfall S; Wright PF; Clemens J; Ivanoff B; Lambert PH
    Bull World Health Organ; 1997; 75(4):295-305. PubMed ID: 9342888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.